2007
DOI: 10.1503/cmaj.1060189
|View full text |Cite
|
Sign up to set email alerts
|

Noncompliance in randomized controlled trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…First, they estimate the effect of randomization to a treatment sequence and not the actual treatment effect that is of main interest. In fact, the treatment effect estimates are often biased toward the null effect (Marasinghe & Amarasinghe, 2007;Lin et al, 2008). Second, the concluding results may not be reproducible due to the potential differential compliance behavior in real-world settings (Frangakis & Rubin, 1999;Robins & Tsiatis, 1991;Hewitt et al, 2006;Lin et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…First, they estimate the effect of randomization to a treatment sequence and not the actual treatment effect that is of main interest. In fact, the treatment effect estimates are often biased toward the null effect (Marasinghe & Amarasinghe, 2007;Lin et al, 2008). Second, the concluding results may not be reproducible due to the potential differential compliance behavior in real-world settings (Frangakis & Rubin, 1999;Robins & Tsiatis, 1991;Hewitt et al, 2006;Lin et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Intention-to-treat analysis measures the effect of randomization to a particular group on the outcome regardless of whether the individual complied with their assigned treatment. There are two main criticisms of intention-to-treat analyses: 1) the treatment effect estimates are biased due to confounding; the bias is often toward the null hypothesis of no effect because the estimate occurs across individuals with different levels of compliance (Marasinghe & Amarasinghe, 2007;Lin et al, 2008). In fact, the intention-to-treat effect estimate will likely diminish as noncompliance increases; 2) the rate of compliance or the compliance pattern in standard clinical practice may not be the same as the rate or the pattern in the clinical trial (Frangakis & Rubin, 1999;Robins & Tsiatis, 1991;Hewitt et al, 2006).…”
Section: Introductionmentioning
confidence: 99%